ZOLEDRONIC ASSOCIATED With Hight Hypofractionated Radiotherapy Dose in Bone Metastases Vertebral Prostate Adenocarcinoma
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
This study will determine the delayed neurotoxicity (12 months) of a hypofractionated high
dose irradiation (3 Gy x 9) associated with zoledronic acid.
The administration of zoledronic acid repeat dosages defined under the Authorisation on the
Market.
All patients receive a total dose of 27 Gy divided into 3 fractions of 9 Gy performed at
least 48 hours apart each, for a treatment to J1, J3 and J5.